Diagnostic and Molecular Histopathology Core

摘要 在NIH/NCI U 54基金（CA 156735）和NIH/NIGMS P20基金（MD 000175）的支持下，我们 建立诊断和分子组织学设施的指定空间和必要仪器 （DMHF）在朱利叶斯L。北卡罗来纳州钱伯斯生物医学/生物技术研究所（BBRI） 中央大学（NCCU）。在NCCU和Lineberger Comprehensive之间的U 54合作伙伴关系中， 我们的DMHF的具体目标如下：（1）进一步开发诊断和治疗癌症的方法， 分子组织病理学实验室;（2）为获资助的研究项目提供组织病理学服务 （3）支持出版物和赠款申请， 组织病理学的专业知识是必要的;（4）培训学生，博士后和技术人员使用 用于研究和教育目的的组织病理学技术。总之，DMHF预计 为研究项目（全面项目1、全面项目3和试验项目2）提供坚实的技术支持， 在U 54助学金期间和未来的教育。我们的目标是确保在癌症方面的伙伴关系 NCCU和LCCC之间的差异研究是成功的。

Abstract With the support of NIH/NCI U54 grant (CA156735) and NIH/NIGMS P20 grant (MD000175), we have designated space and essential instruments to establish a Diagnostic and Molecular Histopathology Facility (DMHF) at the Julius L. Chambers Biomedical/Biotechnology Research Institute (BBRI) of the North Carolina Central University (NCCU). In this renewal U54 partnership between NCCU and Lineberger Comprehensive Cancer Center (LCCC), our DMHF has Specific Aims as follows: (1) To further develop a diagnostic and molecular histopathology laboratory; (2) To provide histopathological service to research projects in this grant proposal and other health disparity studies; (3) To support publications and grant applications when histopathology expertise is needed; and (4) To train students, postdocs and technical staff members to use histopathological techniques for both research and educational purposes. In summary, the DMHF is expected to provide solid technical support to research projects (Full Project 1, Full Project 3 and Pilot Project 2) and education during the U54 grant period and in the future. The goal is to ensure the partnership in cancer disparity research between NCCU and LCCC a success.